drugset / Trial / NCT05820880
Efficacy and Safety of Perindopril 5 mg / Indapamide 1.25 mg / Amlodipine 5 mg Fixed Combination in Hypertension
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to investigate the efficacy and safety of a fixed-dose combination of perindopril 5 mg /indapamide 1.25 mg / amlodipine 5 mg compared to the free combination of the same components (perindopril 4 mg / indapamide 1.25 mg in a single pill and amlodipine 5 mg pill given separately at the same time) in chinese patients with uncontrolled essential hypertension.
Timeline
- Start
- 2019-05-06
- Primary completion
- 2022-02-23
- Completion
- 2022-02-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Amlodipine | Other / unclassified | 5 mg | — |
| Subject | Amlodipine | Other / unclassified | 10 mg | — |
| Subject | Indapamide | Small molecule | 1.25 mg | — |
| Subject | Indapamide | Small molecule | 2.5 mg | — |
| Subject | Perindopril | Small molecule | 4 mg | — |
| Subject | Perindopril | Small molecule | 5 mg | — |
| Subject | Perindopril | Small molecule | 10 mg | — |